Welcome, visitor! [ Register | Login

 

Study Finds Daily Multivitamin Use Offers No Longevity Benefit, May Increase Risk

  • City: OH
  • State: OHio
  • Zip/Postal Code: 1532123
  • Country: United Arab Emirates
  • Listed: July 1, 2024 9:53 am
  • Expires: 6 days, 16 hours
Study Finds Daily Multivitamin Use Offers No Longevity Benefit, May Increase Risk-[Source-The Independent]

Description

Study Finds Daily Multivitamin Use Offers No Longevity Benefit, May Increase Risk
Daily Multivitamin Use Offers No Longevity Benefit | Healthcare 360 Magazine
(Source-The-Independent)

A recent study conducted by researchers from the National Institutes of Health (NIH) has brought into question the common practice of taking daily multivitamins among adults in the United States. Despite approximately one-third of U.S. adults regularly using multivitamins, the study suggests that this habitual practice does not contribute to extending lifespan. Published in JAMA Network Open, the research analyzed extensive data spanning over 20 years and involving 400,000 healthy adults in the U.S.

Study Findings and Analysis
The NIH study revealed striking conclusions regarding the effects of daily multivitamin use on mortality rates. Contrary to popular belief and previous assumptions, the researchers found no significant reduction in the overall risk of death among individuals who took multivitamins compared to those who did not. “The analysis showed that people who took daily multivitamins did not have a lower risk of death from any cause than people who took no multivitamins,” stated the researchers in an NIH press release. Moreover, there were no observable differences in mortality rates related to specific causes such as cancer, heart disease, or cerebrovascular diseases.

Interestingly, the study uncovered a surprising statistic: participants who adhered to daily multivitamin regimens actually exhibited a 4% higher risk of mortality compared to non-users. This finding challenges the commonly held belief that multivitamins serve as a protective health measure. The average age of participants in the study was approximately 61-½ years old, with a notable 164,762 deaths occurring during the follow-up period. To ensure the reliability of their findings, the researchers meticulously adjusted their results for various factors including race, ethnicity, education levels, and nutritional habits.

Context and Implications about Daily Multivitamin
This study builds upon previous research and recommendations regarding multivitamin use. In 2022, the U.S. Preventive Services Task Force conducted a comprehensive analysis that similarly concluded there was insufficient evidence to support the notion that multivitamin consumption leads to improved mortality outcomes. However, the NIH study sought to address these gaps by incorporating a significantly larger participant pool and extending the follow-up period extensively.

By scrutinizing such a vast dataset over an extended timeframe, the researchers aimed to mitigate potential biases that could influence the study’s outcomes. The findings underscore a critical reassessment of widespread dietary practices and public health recommendations related to multivitamin supplementation. While multivitamins continue to be marketed as beneficial for overall health and longevity, the study’s results suggest a need for caution and further research into the long-term effects of these supplements.

In conclusion, the NIH study challenges the assumption that daily multivitamin use offers a protective health advantage in terms of extending lifespan. Instead, it suggests a potential association with increased mortality risk among users. These findings prompt a reevaluation of dietary habits and the necessity of multivitamin supplementation in promoting long-term health outcomes. As further research continues to unfold, the debate over the efficacy and risks of multivitamins in public health remains a topic of significant interest and scrutiny.

No Tags

29 total views, 1 today

  

Listing ID: 43766827ca00e5ea

Report problem

Processing your request, Please wait....
Si prega di attivare i Javascript! / Please turn on Javascript!

Javaskripta ko calu karem! / Bitte schalten Sie Javascript!

S'il vous plaît activer Javascript! / Por favor, active Javascript!

Qing dakai JavaScript! / Qing dakai JavaScript!

Пожалуйста включите JavaScript! / Silakan aktifkan Javascript!